TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,380 | -69.4% | 3,634 | -9.2% | 0.02% | -69.5% |
| Q2 2023 | $99,385 | -40.2% | 4,001 | -63.8% | 0.06% | -35.2% |
| Q1 2023 | $166,252 | -8.2% | 11,054 | -27.8% | 0.09% | -4.2% |
| Q4 2022 | $181,094 | +12.5% | 15,308 | -43.6% | 0.10% | +48.4% |
| Q3 2022 | $161,000 | +41.2% | 27,135 | +0.7% | 0.06% | +52.4% |
| Q2 2022 | $114,000 | +20.0% | 26,935 | +170.9% | 0.04% | -2.3% |
| Q1 2022 | $95,000 | -52.5% | 9,941 | -5.6% | 0.04% | -43.4% |
| Q4 2021 | $200,000 | +8.1% | 10,536 | +89.9% | 0.08% | -6.2% |
| Q3 2021 | $185,000 | -18.5% | 5,549 | -5.0% | 0.08% | -12.9% |
| Q2 2021 | $227,000 | -31.4% | 5,840 | -15.0% | 0.09% | -33.6% |
| Q1 2021 | $331,000 | -5.7% | 6,868 | +1.9% | 0.14% | -4.1% |
| Q4 2020 | $351,000 | -26.9% | 6,743 | -62.4% | 0.15% | -42.1% |
| Q3 2020 | $480,000 | +20.9% | 17,921 | -12.1% | 0.25% | +34.0% |
| Q2 2020 | $397,000 | +13.4% | 20,382 | -42.8% | 0.19% | +30.6% |
| Q1 2020 | $350,000 | -22.7% | 35,606 | -12.7% | 0.14% | +94.6% |
| Q4 2019 | $453,000 | +132.3% | 40,789 | +17.2% | 0.07% | +89.7% |
| Q3 2019 | $195,000 | -38.7% | 34,803 | -5.3% | 0.04% | -41.8% |
| Q2 2019 | $318,000 | -26.7% | 36,741 | -31.9% | 0.07% | -92.7% |
| Q1 2019 | $434,000 | +72.2% | 53,943 | -12.4% | 0.92% | +2046.5% |
| Q4 2018 | $252,000 | +30.6% | 61,557 | +78.8% | 0.04% | +115.0% |
| Q3 2018 | $193,000 | -75.1% | 34,423 | -41.7% | 0.02% | -97.1% |
| Q2 2018 | $776,000 | -39.2% | 59,022 | -34.4% | 0.69% | -38.1% |
| Q1 2018 | $1,277,000 | +272.3% | 89,920 | +114.9% | 1.11% | +157.7% |
| Q4 2017 | $343,000 | -1.7% | 41,833 | +42.0% | 0.43% | +814.9% |
| Q3 2017 | $349,000 | +29.7% | 29,453 | +10.1% | 0.05% | +17.5% |
| Q2 2017 | $269,000 | -59.2% | 26,759 | -52.7% | 0.04% | -65.8% |
| Q1 2017 | $659,000 | +176.9% | 56,542 | +10.6% | 0.12% | +64.8% |
| Q4 2016 | $238,000 | -12.8% | 51,122 | +44.8% | 0.07% | -46.2% |
| Q3 2016 | $273,000 | +27.6% | 35,297 | 0.0% | 0.13% | -17.0% |
| Q2 2016 | $214,000 | +4.9% | 35,297 | +47.2% | 0.16% | -43.4% |
| Q1 2016 | $204,000 | – | 23,986 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |